DexCom Reports Second Quarter 2014 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the 

free GenePool newsletter today!

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2014.

Product revenue grew to $58.2 million for the second quarter of 2014, an increase of 64% from the $35.5 million in product revenue reported for the second quarter of 2013. Total revenue, which included development grant and other revenue, grew to $58.8 million for the second quarter of 2014, an increase of 64% from the same quarter in 2013. Product gross profit totaled $39.5 million for the three months ended June 30, 2014, compared to a product gross profit of $21.8 million for the three months ended June 30, 2013.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC